SCHEMBL765706

SCHEMBL765706

CBc1ccc(C(c2cccc(F)c2)C(C)(C)C(=O)OC)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RPS6KB1 P23443 1/20 0.34
CSNK1D P48730 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
DYRK1A Q13627 1/20 0.34
NTRK2 Q16620 1/20 0.34
AURKB Q96GD4 1/20 0.34
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753573 0.84 HDAC4 (0.41) HDAC4HDAC7HDAC5KDM4ERPS6KB1
SCHEMBL14207676 0.84 HDAC4 (0.38) HDAC4HDAC7HDAC5KDM4ERPS6KB1
SCHEMBL10201034 0.78 KCNQ2 (0.40) HDAC4HDAC7HDAC5KDM4ESMN1; SMN2
SCHEMBL752315 0.76 MAPT (0.40) KDM4ELMNAALDH1A1GAASMN1; SMN2
SCHEMBL10331383 0.71 HDAC4 (0.40) HDAC4HDAC7HDAC5KDM4ELMNA
SCHEMBL10331384 0.71 HDAC4 (0.40) HDAC4HDAC7HDAC5KDM4ELMNA
SCHEMBL14207656 0.71 HDAC4 (0.37) HDAC4HDAC7HDAC5KDM4ECES2
SCHEMBL754423 0.71 HDAC4 (0.40) HDAC4HDAC7HDAC5KDM4ELMNA
SCHEMBL10201035 0.66 KCNQ2 (0.39) SMN1; SMN2TSHROPRM1
SCHEMBL14826292 0.65 KCNN4 (0.50) ALDH1A1CYP2C9CYP2C19TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed